← Evidence map

ReviewEuropean journal of clinical pharmacology2022

Placebo control group in COVID-19 vaccine trials: context and timing matters.

Rafael Dal-RéPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 34837495